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Capsule 
A selection of currently available, published embryo selection algorithms are unable 
to be applied externally and encourage the development of in house, specific embryo 
selection algorithms.  
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Abstract 
 
Objective 
To study the efficacy of five embryo selection algorithms (ESAs) at predicting 
implantation when applied to a large, exclusive set of known implantation embryos 
with the aim of demonstrating the need to develop specific, in-house ESAs.   
Design 
A retrospective, observational analysis.  
Setting 
Fertility Treatment Centre 
Patients 
Nine hundred and eighty embryos derived from 887 treatment cycles performed 
between September 2014 and September 2015. Patients undergoing treatment by 
either IVF or ICSI were included. Embryos were cultured using GTL™ (Vitrolife) at 
5% O2, 89% N2, 6% CO2, 37°C in EmbryoScope® instruments. 
Main outcome Measure 
The difference in implantation rates (IR) of the categories of embryo classification in 
each ESA defined using specificity, sensitivity and positive predictive value, area 
under the receiver operating characteristic curve (AUC) and likelihood ratio. The 
differences in implantation rates (IR) in the categories defined by each ESA were 
also analysed using Fisher’s exact and Kruskall Wallis statistical tests.  
Results 
Each ESA specified time ranges into which embryos must fall to be identified as 
having the highest potential for the stated end point. The ESAs comprised a variety 
of observable events including time to pronuclear fading, 2, 3, 4, 5 and 8 cell, cell 
cycle durations and time to blastulation and blastocyst. When applied to an exclusive 
cohort of known implantation embryos, the PPV for IR were 42.57%, 38.14%, 
44.07%, 38.79%, and 40.45%. The sensitivity was 16.70%, 51.19%, 72.94%, 
98.67%, and 62.33%, respectively. Finally, the specificity was 85.90%, 48.09%, 
42.12%, 2.65% and 42.62%, respectively. The AUC were 0.535, 0.512, 0.575, 0.546 
and 0.583, respectively. There were no significant differences in IR between the 
categories in four of the five ESAs (p>0.05). One of the ESAs resulted in statistically 
significant differences in the embryo classifications in terms of IR (p<0.0001).  
Conclusion 
The results from the examination of the published ESAs examined highlight the need 
for the development of in house, patient, treatment and environment specific ESAs. 
These data suggest that currently available ESAs may not be clinically applicable 
and lose their diagnostic value when externally applied.   
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Introduction 
Traditional methods for embryo selection have been utilised for over twenty years. 
There are numerous morphological parameters that are thought to be useful for 
correct embryo selection; pronuclear morphology (z scoring) 1,2, polar body alignment 
and appearance3, 4, appearance of cytoplasm and zona pellucida5, early cleavage6, 7, 
multinucleation8, 9, 10, and blastomere morphology11, 12, 13. Basic embryo grading, 
including the number of blastomeres, eveness in the size of the blastomeres and the 
level of fragmentation remains the gold standard for embryo selection. However, 
using this method in a traditional sense (with a standard bench top incubator) has 
two limitations; a restricted overview of an embryo’s development and the exposure 
of the embryo to suboptimal temperatures and gas concentrations. With the 
introduction of time lapse imaging, where an image of each embryo is taken every 10 
to 20 minutes, more intricate embryo parameters can be viewed whilst leaving the 
embryos in an undisturbed environment. As the availability of time lapse technologies 
increased, attention was first focused on assessing their clinical safety. Once this 
had been established and the available technologies validated for clinical use14, 15, 16, 
17, 18, research then turned to determining how the time lapse imaging systems could 
be utilised to increase pregnancy rates through in depth embryo analysis and an 
undisturbed culture system.  
 
Through both the research that followed and that performed previously, many 
morphokinetic parameters were identified that correlated with the embryo's ability to 
create a pregnancy both in humans and animals; the appearance and disappearance 
of pronuclei and nuclei at each cell stage3, 19, 20, 21, the length of time between early 
cytokineses22, 23, 24, 25, 26, 27, 28, 29, 30 and initiation of blastulation31. Further embryological 
phenomena have been observed using time lapse imaging including the reabsorption 
of fragments32, direct cleavage of embryos from one to three cells33 and reverse 
cleavage34. These phenomena have been shown to affect an embryos implantation 
potential to varying degrees however, their discovery could lead to more effective 
embryo selection within a laboratory utilising time lapse technology.   
 
Single embryo parameters, such as those named above, have been linked to embryo 
viability (see reference 18 for review) and now these parameters have been used to 
develop embryo selection algorithms (ESAs). These ESAs seek to combine a 
number of morphokinetic parameters that have been linked to an embryo’s viability 
expressed either as formation of a blastocyst, implantation or a live birth. This study 
aims to examine the efficacy of five published ESAs for predicting an embryo’s 
viability, expressed as implantation rate (IR), in a clinically applicable setting21, 27, 31, 35, 
36 aiming to demonstrate the need to develop specific, in-house ESAs. Examined 
ESAs were selected based on their clinical applicability to the test site, assessed 
superficially prior to analysis.  
 
Materials and Methods 
This investigation was a single site, retrospective observational design approved by 
the North West Research Ethics Committee (ref: 14/NW/1043). All procedures and 
protocols complied with UK regulation (Human Fertilisation and Embryology Act, 
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1990, 2008). Data were obtained from 887 treatment cycles between September 
2014 and December 2015. Clinical pregnancy was confirmed by the presence of a 
fetal heartbeat at ultrasound scan at 6 weeks gestation. All treatments included in 
this analysis were from known implantation embryos i.e. a single embryo transfer or 
a double embryo transfer where the transfer of two embryos resulted in either a 
negative test or two fetal heartbeats.  
 
Ovarian Stimulation 
Pituitary down regulation was achieved using either a gonadotrophin releasing 
hormone agonist (buserelin, Suprecur®, Sanofi Aventis, UK) or antagonist (cetrorelix 
acetate, Cetrotide®, Merck Serono, Germany). Ovarian stimulation was performed 
using urine derived or recombinant follicle stimulating hormone (Progynova (Bayer, 
Germany), Fostimon, Merional (IBSA, Switzerland), Menopur® (Ferring Fertility, 
Switzerland), Gonal f® (Merck Serono). Doses were adjusted based on patient 
demographic and response. Patients were given 5000IU of subcutaneous hCG 
(Gonasi® HP, IBSA Pharmaceuticals, Italy) 36 hours prior to oocyte collection. Luteal 
support was provided using 400mg of progesterone pessaries twice daily 
(Cyclogest®, Actavis, UK) until the pregnancy test was taken.  
 
Oocyte retrieval and embryology 
Ultrasound guided oocyte collection was performed transvaginally under sedation 
(Diprivan, Fresenius Kabi, USA). Collected oocyte cumulus complexes were cultured 
in 4 well dishes (Nunc™, Thermo Scientific, USA) with each well containing 0.65ml 
GIVF™ (Vitrolife, Gothenburg, Sweden) covered with 0.35ml OVOIL™ (Vitrolife) in a 
standard incubator (Sanyo Multigas MCO 18M). Sperm preparation was performed 
using a standard gradient separation at 0.3 relative centrifugal force (rcf) for ten 
minutes (ISolate®, Irvine Scientific, USA) followed by two washes at 0.6rcf for ten 
minutes using GIVF™. Those oocytes destined for ICSI were prepared using 
enzymatic (HYASE 10X™, Vitrolife) and mechanical digestion. ICSI was performed 
approximately four hours following collection after which time all injected oocytes 
were placed in individual culture drops of GTL™ (Vitrolife) and cultured in the 
EmbryoScope® (Vitrolife). Those oocytes destined for standard insemination had this 
performed approximately four hours after collection and replaced into a standard 
incubator until fertilisation check the following day. Oocytes were then checked for 
fertilisation approximately 16 to 18 hours post insemination (hpi) and all fertilised 
oocytes along with all unfertilised metaphase II oocytes were placed in individual 
culture drops of GTL™ and cultured in the EmbryoScope®. Embryo selection was 
performed using the national grading scheme37 along with an internally derived, ESA. 
This ESA was used as an additive to morphology at the test site with the latter 
remaining the gold standard. This ESA included three morphokinetic parameters; s2 
(time between t3 and t4), cc3 (time between t4 and t5) and t5 with embryos graded in 
one of eight categories from A+ to D-. Embryo transfer was performed using the 
highest grade embryo(s) either three or five days post collection depending on the 
number of good quality embryos the patient had on day three as well as how many 
were to be transferred. Selected embryos were cultured in EmbryoGlue® (Vitrolife) 
for 10 to 30 minutes in a standard incubator prior to embryo transfer. All embryos 
were cultured at 37°C, 6% CO2, 5% O2, 89% N2 throughout.  
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Analysis of time lapse information 
The image interval on the EmbryoScope® was set to 15 minutes with seven focal 
planes. Images were collected for the duration of culture immediately following ICSI 
or fertilisation check (for IVF derived embryos) to utilisation. Images were assessed 
by a single embryologist for morphokinetic parameters described in table 1 with t0 
defined as the time of insemination/ injection. Accuracy of annotation was 
corroborated bu the participation of the embryologist in an internal quality assurance 
scheme for morphokinetic analysis. Each of the ESAs (table 2) were then 
retrospectively applied to the same cohort of known implantation embryos.  
 
Statistical Analysis  
Positive predictive value, specificity and sensitivity were used to determine the 
efficacy of each of the ESAs. These methods of measurement were chosen for 
analysis due to their relationship to validity and predictive power. Positive predictive 
value was defined as the percentage of embryos creating a fetal heartbeat as well as 
a favourable ESA outcome. Sensitivity was defined as the ability of the ESA to 
correctly classify an embryo as viable. Specificity was defined as the ability of the 
ESA to correctly classify an embryo as non viable.  
 
Each of the test measures were determined using the following calculations: 
Positive predictive value = true positives / (true positives + false positives) 
Sensitivity = true positives / (true positives + false negatives) 
Specificity = true negatives / (true negatives + false positives) 
 
The likelihood ratio was determined using the following calculation: 
Likelihood ratio = sensitivity / (1 – specificity) 
 
The area under the receiver operating characteristic curve (AUC) was calculated for 
each ESA. The IR in each category of the ESA was compared using Fisher’s exact 
test (for ESAs with two outcome categories i.e. true, false) and Kruskall Wallis test 
(for ESAs with more than two outcome categories i.e. A, B, C and D). Results were 
considered statistically significant at p<0.05. Statistical analysis was performed using 
the statistical package Prism® 5 (GraphPad Software©, USA).  
 
 
Results 
A total of 980 known implantation embryos from 887 treatment cycles were subject to 
retrospective analysis to determine the efficacy of five published ESAs (table 2). 531 
of these embryos were created using conventional IVF while 449 were created using 
ICSI. The mean patient age was 33.43 ± 4.52 with an average treatment attempt 
number of 1.37. The primary aetiologies for infertility were male factor (32.2%), 
maternal age (4.1%), ovulatory disorders (9.9%), tubal disorders (6.6%), uterine 
disorders (4.1%), other (including genetic disorder) (0.2%), hormonal deficiency (1%) 
and unexplained (41.8%). Of the 887 treatment cycles, three resulted in a cleavage 
stage embryo transfer while all other transfers were performed on day five 
(blastocyst). 93 double embryo transfers and 794 single embryo transfers were 
performed. 50.2% of treatment cycles were an agonist protocol with the remainder, 
an antagonist protocol. An overall implantation rate of 39.59% was achieved with 388 
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of the 980 embryos implanting and 592 not implanting.   
The positive predictive value for each of the ESAs did not reach above 45% in any 
case (table 2). The sensitivity and specificity were considerably more variable (table 
2), as would be expected, identifying that one ESA had a high sensitivity35 and 
another, a high specificity21. All of the other ESAs had sensitivities and specificities 
close to 50%. The likelihood ratios of all ESAs revealed that there was very little 
predictive power of implantation where a favourable ESA result is obtained (table 2). 
Likelihood ratios range from 0 to infinity and a likelihood ratio close or equal to 1 
indicates a lack of diagnostic value (McGee, 2002); the furthest from 1 that any of the 
ESAs in this investigation reached was 0.26 indicating that an embryo has a 0.26 
increased chance of creating a pregnancy if a favourable ESA outcome is achieved. 
Finally, the AUC analysis revealed values from 0.512 to 0.583 (table 2); a further 
indication of a lack of predictive power of the examined ESAs.  
 
The IR for each category of four of the analysed ESAs did not vary significantly 
(p>0.05) (figure 1). However, the IR for the three categories of the aneuploidy risk 
classification ESA31 varied significantly (p<0.0001). This ESA also had the strongest 
likelihood ratio and positive predictive value (44.07%). Incidentally, the number of 
embryos classified as high risk using this ESA was just three, of which one implanted 
giving this category an IR of 33.33%; a potentially misleading result. The absolute 
difference between the IR of low and medium risk embryos was 15.46% (figure 1).  
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Discussion 
All five of the examined ESAs achieved an AUC less than 0.6, indicating reduced 
predictive capability. None of the ESAs achieved a PPV above 45%, also indicative 
of reduced diagnostic value. Worthy of note is the ESA that was found to have 
statistical significance between the categories of embryo classification31 however, the 
number of embryos classified as high risk was just three of 980. Further validation, 
performed by the developers of this ESA38 using 88 embryos, classified four as high 
risk. Clearly, using this ESA, the chance of an embryo being classified as high risk is 
low which raises issues about the specificity of the ESA especially when evidence 
suggests that over 50% embryos are aneuploid39. With an AUC of 0.575 and a 0.26 
increased chance that an embryo would create a pregnancy if classified as low risk, 
this ESA may not represent a robust, clinically applicable embryo selection. 
Nonetheless, this ESA is the most effective out of the five assessed when a 
combination of specificity, sensitivity, PPV, AUC, likelihood ratio and differences in 
implantations between embryo classification category is considered.  
 
The analyses performed indicate that ESAs available in the literature may not 
provide substantial, additional aid for embryo selection in a clinically relevant setting. 
The current investigation highlights that externally derived ESAs are developed, 
inevitably, under conditions different to that of the adoptive centre (table 3) 
encouraging the development of in house, specific ESAs.. It has been shown that the 
method by which embryos are created (IVF or ICSI) can affect their temporal 
behavior40, 41, 42. In addition to varying treatment types a number of the analysed 
ESAs excluded certain patient groups to avoid confounding factors. This includes 
those with endometriosis, PCOS, severe male factor infertility and maternal age over 
39 years. This exclusion constitutes a proportion of patients that make up a 
significant fraction of patients treated in an IVF laboratory and onto which these 
ESAs could be critically useful. There is evidence to suggest that the reason for 
infertility could affect an embryo’s morphokinetic profile in particular those with 
PCOS43 thus their exclusion in the ESA development is understandable but reduces 
its clinical applicability unless a specific ESA is developed for this specific patient 
group. Furthermore, one group’s ESA was developed using oocyte donors only, a 
clear confounder for the application of this ESA in other centres. The majority of the 
ESAs were developed on embryos created under an agonist protocol. However, one 
group’s ESA development cohort contained a proportion of embryos created under 
an antagonist protocol31 The use of agonist and antagonist protocols has yet to be 
shown to affect an embyro’s morphokinetic profile however, they have been linked to 
embryo quality44, 45 which could indicate that there is a potential for them to also have 
a temporal effect. Finally, and perhaps most significantly, varying culture conditions 
were used in the development of these ESAs. It has been shown that an embryos 
morphokinetic profile is significantly altered in different culture media specifically 
between sequential and single step media46, 47. This means that those developed 
using sequential media may not be effective in selecting embryos cultured in single 
step media, and vice versa. In addition, varying CO2 and O2 gas concentrations were 
used in the development of a number of these published ESAs. Oxygen tension has 
been specifically linked to an embryo’s morphokinetic profile in both humans48 and 
mice49 where those embryos cultured at 20% O2 have reduced developmental rates 
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and the completion of the third cell cycle is significantly delayed. These fundamental 
differences in the development of each ESA need to be seriously considered before 
their external adoption. It is highly unlikely that an external centre will have the same 
patient, treatment and environmental parameters as that of the developing centre.  
 
A further consideration for the use of externally derived ESAs is the subjective nature 
of annotating morphokinetic parameters, the differences in image capture analysis, 
such as the number of focal planes, and the varying definition of t0. The subjective 
nature of annotations creates unreliability in the external application of ESAs. There 
has been some development with this due to the publication of annotation guidelines 
in 201450 however, this will not eliminate the subjectivity completely. Interestingly, 
there are now two commercially available ‘one size fits all’ ESAs that, based on the 
results presented here, should not perform as well as expected. Variations in image 
acquitision is unlikely to create significant disparity however, coupled with the 
variability between ‘annotaters’, an increasing level of inaccuracy could be created. 
Although undefined in some of the publications, the definition of t0 varies between 
groups with some using t0 as the time of insemination or injection, the inaugural and 
arguably the most common method, and others the mid-point of ICSI. It has now 
been largely accepted that the use of insemination/ injection is arbitrary and the 
exact moment that the sperm enters the oocyte is indeterminate for IVF cases and, 
where possible, time of pronuclei fading should be used as t0.  
 
Conclusion 
The development of ESAs, thus far, has not involved the control of confounding 
factors such as media type, patient age and treatment type, except inadvertently by 
virtue of availability. They are often developed under the environmental parameters 
available in the laboratory performing the development and thus are clinically 
relevant in these cases alone. For external application, the ESAs lose their predictive 
capabilities. The primary objective of ESAs is to allow the selection of the best 
embryo from a cohort in a clinical setting. Those presented here, clarify that embryo 
morphokinetics could be used for embryo selection however, they do not offer 
clinically relevant means to aid in embryo selection in other laboratories unless the 
development criteria are also adopted. The collective contribution of confounding 
factors means that derived ESAs can only be applied to that on which they were 
developed and when applied to a heterogeneous cohort of embryos, as would be 
found in an IVF laboratory, the capability of the ESA to detect the most viable embryo 
diminishes. Further research needs to focus on the development of ESAs that are 
specific to subgroups of patients, environments and treatments. At the very least, 
embryology laboratories should proceed with caution when implementing ESAs 
derived from published sources and consider thorough in house validation of such 
ESAs before clinical use, if at all.  
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Figure 1 caption 
Implantation rates (IRs) of the embryo classification categories in each of the 
analysed ESAs.  
Azzarello et al, 2012; IR of those embryos where pronuclear fading (PNf) occurred 
after 20.75hpi (n=832, 37.74%) and those that faded before 20.75hpi (n=148, 
42.57%) (p>0.05, Fisher’s exact test). Cruz et al, 2012; IR of embryos classified as A 
(t5 = 48.8-56.6hpi and s2 ≤0.76h, n=365), B (t5 <48.8 OR >56.6 and s2  ≤0.76h, 
n=141), C (t5 = 48.8-56.6hpi and s2 >0.76h, n=354) and D (t5 <48.8 OR >56.6 and 
s2 >0.76h, n=120) with respective IR of 41.1%, 30.5%, 39.83% and 35.83% (p>0.05, 
Kruskal-Wallis test). Campbell et al, 2013; IR for embryos classified as low risk (tSB 
<92.2hpi and tB <122.9hpi, n=624), medium risk (tSB ≥96.2 and tB ≤122.9hpi, 
n=353) and high risk (tB ≥122.9hpi, n=3) with respective IR of 44.07%, 28.61% and 
33.33% (p<0.05, Kruskall-Wallis test). Chamayou et al, 2013; IR of those embryos 
where cc3 (t5-t3) occurred between 9.7-21h (n=959, 23.81%) and those that did not 
(n=21, 38.79%) (p>0.05, Fisher’s exact test). Dal Canto et al, 2012; IR of embryos 
where t8 occurred between 51.6-70.4hpi (n=581, 35.59%) and those that did not 
(n=399, 40.45%) (p>0.05, Fisher’s exact test). 
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Annotated morphokinetic parameter Definition 
tPNf Time when both pronuclei had faded 
t2 Time to 2-cell 
t3 Time to 3-cell 
t4 Time to 4-cell 
t5 Time to 5-cell 
t8 Time to 8-cell 
tSB Time to start of blastulation; when first signs of a cavity were visible 
tB Time to full blastocyst; when the blastocoele filled the embryo with <10% increase in it’s 
diameter 
Calculated morphokinetic parameters 
s2 Time of synchrony of second cell cycle (t4-t3) 
cc3 Time of third cell cycle (t5-t3) 
Table 1; summary of morphokinetic parameters used for analysis including those requiring annotation as well as those requiring calculation 
from the annotated values.  
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 Model type Parameter Time frame Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
AUC Likelihood ratio Category analysis 
A
z
a
re
llo
 
e
t 
a
l,
 2
0
1
2
 Selection/ 
deselection 
PNf  >20h 45m 16.70 85.90 42.57 0.535 1.19 0.2724  
(Fisher’s exact) 
C
ru
z
 
e
t 
a
l,
 2
0
1
2
 Hierarchical t5  
s2 
48.8-56.6h 
≤0.76h 
51.19 48.09 38.14 0.512 0.99 0.1402  
(Kruskal-Wallis) 
C
a
m
p
b
e
ll 
e
t 
a
l,
 2
0
1
3
 
Risk classification 
model 
tSB 
tB 
Low risk:  
tSB <96.2hpi 
tB <122.9hpi 
Medium risk: 
tSB ≥96.2hpi 
tB <122.9hpi 
High risk: 
tB ≥122.9hpi 
72.94 42.12 44.07 0.575 1.26 <0.0001****  
(Kruskall-Wallis) 
C
h
a
m
a
y
o
u
 
e
t 
a
l,
 2
0
1
3
 Selection/ 
deselection 
cc3 9.7-21h 98.67 2.65 38.79 0.546 1.01 0.1817  
(Fisher’s exact) 
D
a
l 
C
a
n
to
 
e
t 
a
l,
 2
0
1
2
 Selection/ 
deselection 
t8 54.9 ± 5.2h 62.33 42.62 40.45 0.583 1.09 0.1415  
(Fisher’s exact) 
Table 2; summary of embryo selection criterion and main results.  
PNf; pronuclear fading.  t5; time to 5-cell. s2; time between 3-cell and 4-cell. tSB; time to start of blastulation. tB; time to full blastocyst. cc3; time between 3-cell and 5-cell. t8; time to 
8-cell. PPV; positive predictive value. AUC; area under the receiver operating characteristic curve. 
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 n 
(embryos) 
n 
(cycles) 
Fertilisation 
method 
End point Exclusion criteria Inclusion criteria Image capture 
interval (mins) 
Protocol Culture Media 
change 
Transfer 
day 
A
z
a
re
llo
 
e
t 
a
l,
 2
0
1
2
 
159 130 ICSI LBR - Embryos transferred at 4-cell 
stage with equal blastomeres 
and <25% fragmentation, 
autologous gametes, 
female age ≤39, 
male factor infertility 
(1-5x105 motile sperm/ 
ejaculate) 
20 Agonist  Cook® 
5.5% CO2, 5% O2, 
89.5% N2 
No 2 (44hpi) 
C
ru
z
 
e
t 
a
l,
 2
0
1
2
 834 165 ICSI BFR - Oocyte donor meeting all 
required criteria for donation 
programme 
20 Agonist Global IVF medium 
(LifeGlobal) 
6% CO2, 21% O2, 
37.4°C 
Yes 5 
C
a
m
p
b
e
ll 
e
t 
a
l,
 2
0
1
3
 88 25 ICSI CPR and 
LBR 
- Patients undergoing a cycle 
inclusive of PGS 
20 Agonist 
(75%) 
Antagonist 
(25%) 
Global IVF medium 
(LifeGlobal) 
5.5% CO2, 5% O2,  
89.5% N2 
Yes 5 
C
h
a
m
a
y
o
u
 
e
t 
a
l,
 2
0
1
3
 178 78 ICSI BFR Severe endometriosis, 
premature ovarian failure, 
severe  
asthenoteratozoospermia 
Fresh gametes 20  Agonist Quinn’s Advantage 
(SAGE)  
5% CO2, 5% O2 
Yes 5 
D
a
l 
C
a
n
to
 
e
t 
a
l,
 2
0
1
2
      134 71 IVF (22) and 
ICSI (49) 
IR - Indication for standard IVF or 
ICSI due to male factor, tubal 
factor, stage I or II 
endometriosis or PCOS, 
maternal age 27-42. 
20 Agonist ISM1 (day 1-3) 
BlastAssist (day 3-5) 
6% CO2, 5% O2,  
89% N2 
Yes 3 and 5 
Table 3; summary of publications used for examination of efficacy of selection criteria. ICSI; intracytoplasmic sperm injection. IVF; in vitro fertilisation. LBR; live birth rate. BFR; blastocyst formation rate. CPR; 
clinical pregnancy rate.  IR; implantation rate. PGS; preimplantation genetic screening.  PCOS; polycystic ovary syndrome. CO2; carbon dioxide. O2; oxygen. N2; nitrogen.  hpi; hours post insemination. 
